OCUL
Price
$7.95
Change
-$0.04 (-0.50%)
Updated
Jan 23, 10:35 AM (EDT)
Capitalization
1.26B
42 days until earnings call
RAPT
Price
$1.24
Change
+$0.02 (+1.64%)
Updated
Jan 23, 10:37 AM (EDT)
Capitalization
161.05M
42 days until earnings call
Ad is loading...

OCUL vs RAPT

Header iconOCUL vs RAPT Comparison
Open Charts OCUL vs RAPTBanner chart's image
Ocular Therapeutix
Price$7.95
Change-$0.04 (-0.50%)
Volume$285
Capitalization1.26B
RAPT Therapeutics
Price$1.24
Change+$0.02 (+1.64%)
Volume$100
Capitalization161.05M
OCUL vs RAPT Comparison Chart
Loading...
OCUL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RAPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
OCUL vs. RAPT commentary
Jan 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OCUL is a Hold and RAPT is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 23, 2025
Stock price -- (OCUL: $7.99 vs. RAPT: $1.22)
Brand notoriety: OCUL and RAPT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: OCUL: 107% vs. RAPT: 16%
Market capitalization -- OCUL: $1.26B vs. RAPT: $161.05M
OCUL [@Biotechnology] is valued at $1.26B. RAPT’s [@Biotechnology] market capitalization is $161.05M. The market cap for tickers in the [@Biotechnology] industry ranges from $355.19B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OCUL’s FA Score shows that 0 FA rating(s) are green whileRAPT’s FA Score has 0 green FA rating(s).

  • OCUL’s FA Score: 0 green, 5 red.
  • RAPT’s FA Score: 0 green, 5 red.
According to our system of comparison, OCUL is a better buy in the long-term than RAPT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OCUL’s TA Score shows that 3 TA indicator(s) are bullish while RAPT’s TA Score has 3 bullish TA indicator(s).

  • OCUL’s TA Score: 3 bullish, 3 bearish.
  • RAPT’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, OCUL is a better buy in the short-term than RAPT.

Price Growth

OCUL (@Biotechnology) experienced а -1.72% price change this week, while RAPT (@Biotechnology) price change was +1.67% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.70%. For the same industry, the average monthly price growth was +2.32%, and the average quarterly price growth was -2.48%.

Reported Earning Dates

OCUL is expected to report earnings on May 09, 2025.

RAPT is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (+1.70% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OCUL($1.26B) has a higher market cap than RAPT($161M). OCUL YTD gains are higher at: -6.440 vs. RAPT (-22.785). RAPT has higher annual earnings (EBITDA): -113.61M vs. OCUL (-155.92M). OCUL has more cash in the bank: 427M vs. RAPT (97.9M). RAPT has less debt than OCUL: RAPT (5.12M) vs OCUL (75.1M). OCUL has higher revenues than RAPT: OCUL (61.4M) vs RAPT (0).
OCULRAPTOCUL / RAPT
Capitalization1.26B161M780%
EBITDA-155.92M-113.61M137%
Gain YTD-6.440-22.78528%
P/E RatioN/AN/A-
Revenue61.4M0-
Total Cash427M97.9M436%
Total Debt75.1M5.12M1,467%
FUNDAMENTALS RATINGS
OCUL: Fundamental Ratings
OCUL
OUTLOOK RATING
1..100
66
VALUATION
overvalued / fair valued / undervalued
1..100
47
Fair valued
PROFIT vs RISK RATING
1..100
78
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
50
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
OCULRAPT
RSI
ODDS (%)
N/A
Bearish Trend 16 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 16 days ago
90%
Bullish Trend 16 days ago
86%
Momentum
ODDS (%)
Bullish Trend 16 days ago
86%
Bearish Trend 16 days ago
90%
MACD
ODDS (%)
Bullish Trend 16 days ago
85%
N/A
TrendWeek
ODDS (%)
Bullish Trend 16 days ago
83%
Bearish Trend 16 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 16 days ago
88%
Bullish Trend 16 days ago
83%
Advances
ODDS (%)
Bullish Trend 17 days ago
82%
Bullish Trend 18 days ago
84%
Declines
ODDS (%)
Bearish Trend 25 days ago
83%
Bearish Trend 16 days ago
89%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bearish Trend 16 days ago
90%
N/A
View a ticker or compare two or three
Ad is loading...
OCUL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RAPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CZMGX21.410.32
+1.52%
Multi-Manager Growth Strategies Inst
MMVYX9.96N/A
N/A
MassMutual Small Company Val Svc
GGZPX23.04N/A
N/A
Goldman Sachs Enh Cor EqFund-ShareclassP
RPMYX10.72-0.01
-0.09%
Reinhart International PMV Advisor
OAKEX18.27-0.03
-0.16%
Oakmark International Small Cap Investor

OCUL and

Correlation & Price change

A.I.dvisor indicates that over the last year, OCUL has been loosely correlated with RCUS. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if OCUL jumps, then RCUS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OCUL
1D Price
Change %
OCUL100%
-1.24%
RCUS - OCUL
46%
Loosely correlated
-5.23%
PLRX - OCUL
46%
Loosely correlated
-1.36%
EYPT - OCUL
44%
Loosely correlated
+14.29%
XENE - OCUL
41%
Loosely correlated
+0.54%
RXRX - OCUL
40%
Loosely correlated
+8.87%
More

RAPT and

Correlation & Price change

A.I.dvisor indicates that over the last year, RAPT has been closely correlated with JBPHF. These tickers have moved in lockstep 79% of the time. This A.I.-generated data suggests there is a high statistical probability that if RAPT jumps, then JBPHF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RAPT
1D Price
Change %
RAPT100%
+1.67%
JBPHF - RAPT
79%
Closely correlated
N/A
AXON - RAPT
48%
Loosely correlated
+0.33%
SNDX - RAPT
45%
Loosely correlated
+2.41%
OCUL - RAPT
42%
Loosely correlated
-1.24%
AGIO - RAPT
41%
Loosely correlated
+2.50%
More